A next-generation live-attenuated yellow fever vaccine (vYF) demonstrated noninferior immunogenicity compared to the standard vaccine, with nearly universal seroconversion by one month after ...
Hosted on MSN
Next-gen flu vaccines use proteolysis-targeting to boost safety and cross-strain immunity in animal models
Recently, Prof. Si Longlong's team from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences constructed a library of live-attenuated influenza A vaccines that utilize ...
A research team has achieved a significant breakthrough in developing broadly protective, live-attenuated influenza vaccines (LAIV). These innovative LAIV platforms offer potential to develop ...
PROTAR viruses efficiently reproduce owing to TEVp-mediated viral protein stabilization in TEVp-expressing cells and are attenuated by proteasome-mediated viral protein degradation in conventional ...
A next-generation, live-attenuated yellow fever vaccine, vYF, was developed in Vero cells to improve vaccine supply and availability. The safety of and immune response to vYF as compared with those of ...
Long regarded as disease-specific, some widely used vaccines may confer broader health benefits that extend beyond protection against intended pathogens. Evidence suggests that certain live attenuated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results